Managing hyperlipidaemia in the elderly: special considerations for a population at high risk (Q36445474)

14 August 2017

1 reference

title

Managing hyperlipidaemia in the elderly: special considerations for a population at high risk (English)

1 reference

14 August 2017

1 reference

1

Wilbert S Aronow

1 reference

14 August 2017

publication date

1 January 2006

1 reference

14 August 2017

1 reference

14 August 2017

volume

23

1 reference

14 August 2017

issue

3

1 reference

14 August 2017

page(s)

181-189

1 reference

Serum cholesterol as a prognostic factor after myocardial infarction: the Framingham Study.

14 August 2017

cites work

1 reference

https://api.crossref.org/works/10.2165%2F00002512-200623030-00001

High blood cholesterol in elderly men and the excess risk for coronary heart disease

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F00002512-200623030-00001

Association of abnormal serum lipids in elderly persons with atherosclerotic vascular disease and dementia, atherosclerotic vascular disease without dementia, dementia without atherosclerotic vascular disease, and no dementia or atherosclerotic vasc

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F00002512-200623030-00001

Effect of pravastatin on cardiovascular events in older patients with myocardial infarction and cholesterol levels in the average range. Results of the Cholesterol and Recurrent Events (CARE) trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F00002512-200623030-00001

Incidence of new atherothrombotic brain infarction in older persons with prior myocardial infarction and serum low-density lipoprotein cholesterol >or=125 mg/dl treated with statins versus no lipid-lowering drug

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F00002512-200623030-00001

Reduction of new coronary events and new atherothrombotic brain infarction in older persons with diabetes mellitus, prior myocardial infarction, and serum low-density lipoprotein cholesterol >/=125 mg/dl treated with statins

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F00002512-200623030-00001

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F00002512-200623030-00001

Should the NCEP III guidelines be changed in elderly and younger persons at high risk for cardiovascular events?

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F00002512-200623030-00001

Plasma lipids and lipoproteins and the incidence of cardiovascular disease in the very elderly. The Bronx Aging Study

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F00002512-200623030-00001

Cholesterol-lowering therapy in women and elderly patients with myocardial infarction or angina pectoris: findings from the Scandinavian Simvastatin Survival Study (4S)

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F00002512-200623030-00001

Underutilization of measurement of serum low-density lipoprotein cholesterol levels and of lipid-lowering therapy in older patients with manifest atherosclerotic disease

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F00002512-200623030-00001

Utilization of lipid-lowering drugs in elderly persons with increased serum low-density lipoprotein cholesterol associated with coronary artery disease, symptomatic peripheral arterial disease, prior stroke, or diabetes mellitus before and after an

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F00002512-200623030-00001

Prevalence of severe arteriosclerosis obliterans in patients with diabetes mellitus. Relation to smoking and form of therapy

21 January 2018

1 reference

12 December 2020

Effects of simvastatin on walking performance and symptoms of intermittent claudication in hypercholesterolemic patients with peripheral vascular disease

1 reference

12 December 2020

Effect of hydroxymethylglutaryl coenzyme a reductase inhibitors on the progression of calcific aortic stenosis

1 reference

12 December 2020

The effect of pravastatin on coronary events after myocardial infarction in patients with average cholesterol levels. Cholesterol and Recurrent Events Trial investigators

1 reference

12 December 2020

Effect of intensive compared with moderate lipid-lowering therapy on progression of coronary atherosclerosis: a randomized controlled trial

1 reference

12 December 2020

Correlation of serum lipids with the presence or absence of atherothrombotic brain infarction and peripheral arterial disease in 1,834 men and women aged > or = 62 years

1 reference

12 December 2020

Long-term effectiveness and safety of pravastatin in 9014 patients with coronary heart disease and average cholesterol concentrations: the LIPID trial follow-up

1 reference

12 December 2020

Statin therapy is associated with improved survival in ischemic and non-ischemic heart failure

1 reference

12 December 2020

Cholesterol reduction with atorvastatin improves walking distance in patients with peripheral arterial disease

1 reference

12 December 2020

Prevention of coronary and stroke events with atorvastatin in hypertensive patients who have average or lower-than-average cholesterol concentrations, in the Anglo-Scandinavian Cardiac Outcomes Trial--Lipid Lowering Arm (ASCOT-LLA): a multicentre ra

1 reference

12 December 2020

Prevention of Cardiovascular Events and Death with Pravastatin in Patients with Coronary Heart Disease and a Broad Range of Initial Cholesterol Levels

1 reference

12 December 2020

Effect of simvastatin versus placebo on treadmill exercise time until the onset of intermittent claudication in older patients with peripheral arterial disease at six months and at one year after treatment

1 reference

12 December 2020

Incidence of new coronary events in older persons with prior myocardial infarction and serum low-density lipoprotein cholesterol > or = 125 mg/dl treated with statins versus no lipid-lowering drug

1 reference

12 December 2020

Is elevated serum cholesterol level a risk factor for coronary heart disease in the elderly?

1 reference

12 December 2020

Plasma lipoproteins and apolipoproteins as predictors of cardiovascular risk and treatment benefit in the PROspective Study of Pravastatin in the Elderly at Risk (PROSPER).

1 reference

12 December 2020

Frequency of new coronary events in older persons with peripheral arterial disease and serum low-density lipoprotein cholesterol > or = 125 mg/dl treated with statins versus no lipid-lowering drug

1 reference

12 December 2020

Frequency of congestive heart failure in older persons with prior myocardial infarction and serum low-density lipoprotein cholesterol > or = 125 mg/dl treated with statins versus no lipid-lowering drug

1 reference

12 December 2020

Risk factors for new coronary events in a large cohort of very elderly patients with and without coronary artery disease

1 reference

12 December 2020

Executive Summary of The Third Report of The National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, And Treatment of High Blood Cholesterol In Adults (Adult Treatment Panel III)

1 reference

12 December 2020

Gemfibrozil for the secondary prevention of coronary heart disease in men with low levels of high-density lipoprotein cholesterol. Veterans Affairs High-Density Lipoprotein Cholesterol Intervention Trial Study Group

1 reference

12 December 2020

HDL Cholesterol Predicts Coronary Heart Disease Mortality in Older Persons

1 reference

12 December 2020

Plasma high density lipoproteins in coronary, cerebral and peripheral vascular disease The influence of various risk factors

1 reference

12 December 2020

MRC/BHF Heart Protection Study of cholesterol lowering with simvastatin in 20,536 high-risk individuals: a randomised placebo-controlled trial

1 reference

12 December 2020

Reduction of coronary events with aspirin in older patients with prior myocardial infarction treated with and without statins

1 reference

12 December 2020

Association of cholesterol levels, hydroxymethylglutaryl coenzyme-A reductase inhibitor treatment, and progression of aortic stenosis in the community

1 reference

12 December 2020

Association of coronary risk factors and use of statins with progression of mild valvular aortic stenosis in older persons

1 reference

12 December 2020

Implications of recent clinical trials for the National Cholesterol Education Program Adult Treatment Panel III guidelines

1 reference

12 December 2020

Follow-up study of patients randomized in the Scandinavian simvastatin survival study (4S) of cholesterol lowering

1 reference

12 December 2020

Pravastatin in elderly individuals at risk of vascular disease (PROSPER): a randomised controlled trial

1 reference

12 December 2020

Intensive versus moderate lipid lowering with statins after acute coronary syndromes

1 reference

12 December 2020

The association of dyslipoproteinemia with symptoms and signs of peripheral arterial disease. The Lipid Research Clinics Program Prevalence Study

1 reference

12 December 2020

Effect of simvastatin on ischemic signs and symptoms in the Scandinavian simvastatin survival study (4S)

1 reference

12 December 2020

National Cholesterol Education Program's recommendations, and implications of "missing" high-density lipoprotein cholesterol in cardiac rehabilitation programs

1 reference

12 December 2020

Underutilization of lipid-lowering drugs in older persons with prior myocardial infarction and a serum low-density lipoprotein cholesterol > 125 mg/dl

1 reference

12 December 2020

Correlation of serum lipids with the presence or absence of coronary artery disease in 1,793 men and women aged > or = 62 years

1 reference

12 December 2020

Cardiovascular risk factors in the elderly

1 reference

12 December 2020

Randomised trial of cholesterol lowering in 4444 patients with coronary heart disease: the Scandinavian Simvastatin Survival Study (4S)

1 reference

12 December 2020

Prevalence of peripheral arterial disease and its correlation with risk factors for peripheral arterial disease in elderly patients in a long-term health care facility

1 reference

12 December 2020

Effects of atorvastatin on early recurrent ischemic events in acute coronary syndromes: the MIRACL study: a randomized controlled trial

1 reference

12 December 2020

10.2165/00002512-200623030-00001

Identifiers

DOI

1 reference

Dimensions Publication ID

14 August 2017

1015069031

0 references

1 reference